Selecting anti-HIV therapies based on a variety of genomic and clinical factors. - Michal Rosen-Zvi; André Altmann; Mattia Prosperi; Ehud Aharoni; Hani Neuvirth; Anders Sönnerborg; Eugen Schülter; Daniel Struck; Yardena Peres; Francesca Incardona; Rolf Kaiser; Maurizio Zazzi; et al. (ISMB, 2008)

PhyloGeoTool: interactively exploring large phylogenies in an epidemiological context. - Pieter Libin; Ewout Vanden Eynden; Francesca Incardona; Ann Nowé; Antonia Bezenchek; EucoHIV Study Group; Anders Sönnerborg; Anne-Mieke Vandamme; Kristof Theys; Guy Baele (Bioinform., 2017)

Factorial HMMs with Collapsed Gibbs Sampling for Optimizing Long-term HIV Therapy. - Amit Gruber; Chen Yanover; Tal El-Hay; Anders Sönnerborg; Vanni Borghi; Francesca Incardona; Yaara Goldschmidt (AISTATS, 2018)

The Health Gym: Synthetic Health-Related Datasets for the Development of Reinforcement Learning Algorithms. - Nicholas I-Hsien Kuo; Mark N. Polizzotto; Simon Finfer; Federico Garcia; Anders Sönnerborg; Maurizio Zazzi; Michael Böhm; Louisa Jorm; Sebastiano Barbieri (CoRR, 2022)

Incorporating temporal dynamics of mutations to enhance the prediction capability of antiretroviral therapy's outcome for HIV-1. - Giulia Di Teodoro; Martin Pirkl; Francesca Incardona; Ilaria Vicenti; Anders Sönnerborg; Rolf Kaiser; Laura Palagi; Maurizio Zazzi; Thomas Lengauer (CoRR, 2023)

Generating synthetic clinical data that capture class imbalanced distributions with generative adversarial networks: Example using antiretroviral therapy for HIV. - Nicholas I-Hsien Kuo; Federico Garcia; Anders Sönnerborg; Michael Böhm; Rolf Kaiser; Maurizio Zazzi; Mark N. Polizzotto; Louisa Jorm; Sebastiano Barbieri (J. Biomed. Informatics, 2023)

A graph neural network-based model with out-of-distribution robustness for enhancing antiretroviral therapy outcome prediction for HIV-1. - Giulia Di Teodoro; Federico Siciliano; Valerio Guarrasi; Anne-Mieke Vandamme; Valeria Ghisetti; Anders Sönnerborg; Maurizio Zazzi; Fabrizio Silvestri; Laura Palagi (Comput. Medical Imaging Graph., 2025)